Krystal Biotech, Inc.
← Back to KRYS Overview

Krystal Biotech, Inc. (KRYS)

Solvency & Capital Structure

Total Debt

$9.1M

Net Debt

-$814.3M

Krystal Biotech, Inc. currently has $9.1M in total debt. Net debt is -$814.3M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

KRYSQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.010.82-0.81Net Cash1.400.7%
2025-12-310.010.83-0.82Net Cash1.330.7%
2025-09-300.010.73-0.72Net Cash1.240.8%
2025-06-300.010.68-0.67Net Cash1.140.9%
2025-03-310.010.62-0.61Net Cash1.070.9%
2024-12-310.010.60-0.59Net Cash1.060.7%
2024-09-300.010.59-0.58Net Cash0.980.8%
2024-06-300.010.56-0.55Net Cash0.920.8%
2024-03-310.010.54-0.53Net Cash0.850.9%
2023-12-310.010.53-0.52Net Cash0.821.0%
2023-09-300.010.56-0.55Net Cash0.791.1%
2023-06-300.010.48-0.47Net Cash0.681.2%
2023-03-310.010.35-0.34Net Cash0.531.6%
2022-12-310.010.38-0.37Net Cash0.561.6%
2022-09-300.010.39-0.39Net Cash0.581.6%
2022-06-300.010.43-0.42Net Cash0.601.5%
2022-03-310.010.43-0.43Net Cash0.621.5%
2021-12-310.010.44-0.43Net Cash0.631.3%
2021-09-300.010.34-0.33Net Cash0.451.8%
2021-06-300.010.37-0.36Net Cash0.441.8%
2021-03-310.000.40-0.40Net Cash0.440.9%
2020-12-310.010.27-0.26Net Cash0.313.7%
2020-09-300.000.29-0.28Net Cash0.311.0%
2020-06-300.000.30-0.29Net Cash0.321.0%
2020-03-310.000.19-0.18Net Cash0.211.6%
2019-12-310.000.19-0.19Net Cash0.211.6%
2019-09-300.000.20-0.20Net Cash0.211.6%
2019-06-300.000.20-0.19Net Cash0.211.6%
2019-03-310.000.11-0.10Net Cash0.122.9%
2018-12-310.000.11-0.11Net Cash0.120.0%
2018-09-300.000.05-0.05Net Cash0.050.0%
2018-06-300.000.05-0.05Net Cash0.050.0%
2018-03-310.000.05-0.05Net Cash0.050.0%
2017-12-310.000.05-0.05Net Cash0.050.0%
2017-09-300.000.05-0.05Net Cash0.050.0%
2017-06-300.000.00-0.00Net Cash0.000.0%
2017-03-310.000.000.000.0099.6%
2016-12-310.000.00-0.00Net Cash0.0084.5%